Green Ridge Care Center in Scranton, PA

Green Ridge Care Center is a medicare and medicaid certified nursing home in Scranton, Pennsylvania. It is located in Lackawanna county at 2741 Boulevard Avenue, Scranton, Pennsylvania 18509. You can reach out to the office of Green Ridge Care Center via phone at (570) 344-6121. This skilled nursing facility has 95 federally certified beds with average occupancy rate of 85.58%. The nursing facility is classified as "Continuing Care Retirement Community" by CMS and its legal business name is Green Ridge Healthcare Group, Llc and has the following ownership type - For Profit - Corporation.

Green Ridge Care Center (Medicare CCN 395067) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1972 (52 years certified) and the last quality survey was conducted in February, 2020.

Name	Green Ridge Care Center
Location	2741 Boulevard Avenue, Scranton, Pennsylvania
Certified By	Medicare and Medicaid
No. of Certified Beds	95
Occupancy Rate	85.58%
Medicare ID (CCN)	395067
Legal Business Name	Green Ridge Healthcare Group, Llc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Green Ridge Care Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1194015784
Organization Name	GREEN RIDGE HEALTHCARE GROUP, LLC
Doing Business As	GREEN RIDGE CARE CENTER
Address	2741 Boulevard Ave, Scranton, PA 18509
Phone Number	570-344-6121

News Archive

Gender-based sex selection harms women's health in Asia, U.N. report says

"Gender biased sex selection, widespread in many parts of Asia, has serious and profoundly debilitating effects on the mental and physical health of women, says a report by five United Nations agencies," BMJ reports.

Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment

U.N. commission on the status of women opens in New York

Kicking off the two-week 55th Annual Session of the U.N. Commission on the Status of Women in New York on Tuesday, Michelle Bachelet, the first under-secretary-general and executive director of U.N. Women, highlighted the role of gender equality in country development, peace and security, Angola Press reports (2/23).

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

The U.S. Food and Drug Administration has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

Read more Medical News

› Verified 1 days ago

NPI Number	1386701118
Organization Name	GREEN RIDGE HEALTH CARE CENTER, LLC
Address	2741 Boulevard Ave, Scranton, PA 18509
Phone Number	570-344-6121

News Archive

Gender-based sex selection harms women's health in Asia, U.N. report says

"Gender biased sex selection, widespread in many parts of Asia, has serious and profoundly debilitating effects on the mental and physical health of women, says a report by five United Nations agencies," BMJ reports.

Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment

U.N. commission on the status of women opens in New York

Kicking off the two-week 55th Annual Session of the U.N. Commission on the Status of Women in New York on Tuesday, Michelle Bachelet, the first under-secretary-general and executive director of U.N. Women, highlighted the role of gender equality in country development, peace and security, Angola Press reports (2/23).

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

The U.S. Food and Drug Administration has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

Read more Medical News

› Verified 1 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Green Ridge Care Center are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Green Ridge Care Center give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Gender-based sex selection harms women's health in Asia, U.N. report says

"Gender biased sex selection, widespread in many parts of Asia, has serious and profoundly debilitating effects on the mental and physical health of women, says a report by five United Nations agencies," BMJ reports.

Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment

U.N. commission on the status of women opens in New York

Kicking off the two-week 55th Annual Session of the U.N. Commission on the Status of Women in New York on Tuesday, Michelle Bachelet, the first under-secretary-general and executive director of U.N. Women, highlighted the role of gender equality in country development, peace and security, Angola Press reports (2/23).

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

The U.S. Food and Drug Administration has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

Read more Medical News

› Verified 1 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Green Ridge Care Center is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	13.27	14.46
Percentage of long-stay residents who lose too much weight	10.71	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	40	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	0.37	1.79
Percentage of long-stay residents with a urinary tract infection	0.34	2.65
Percentage of long-stay residents who have depressive symptoms	0.67	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	4.89	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	97.72	93.87
Percentage of long-stay residents who received an antipsychotic medication	9.9	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	87.02	83.88
Percentage of short-stay residents who newly received an antipsychotic medication	0	1.79
Percentage of long-stay residents whose ability to move independently worsened	19.82	17.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication	26.35	19.7
Percentage of high risk long-stay residents with pressure ulcers	2.99	7.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine	99.71	95.98
Percentage of short-stay residents who made improvements in function	70.72	67.99
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine	92.61	82.93

Nursing Homes in Scranton, PA

Green Ridge Care Center Location: 2741 Boulevard Avenue, Scranton, Pennsylvania 18509 Phone: (570) 344-6121
Jewish Home Of Eastern Pennsyl Location: 1101 Vine Street, Scranton, Pennsylvania 18510 Phone: (570) 344-6177
Gardens At Scranton, The Location: 824 Adams Avenue, Scranton, Pennsylvania 18510 Phone: (570) 346-5704
Marywood Heights Location: 2500 Adams Avenue, Scranton, Pennsylvania 18509 Phone: (570) 343-4065
Linwood Nursing And Rehabilitation Center Location: 100 Linwood Avenue, Scranton, Pennsylvania 18505 Phone: (570) 346-7381
Mountain View Care And Rehabilitation Center Location: 2309 Stafford Avenue, Scranton, Pennsylvania 18505 Phone: (570) 341-0050

Nursing Home

A nursing home (also called skilled nursing facility) is a facility or distinct part of an institution whose primary function is to provide medical, continuous nursing, and other health and social services to patients who are not in an acute phase of illness requiring services in a hospital, but who require primary restorative or skilled nursing services on an inpatient basis above the level of intermediate or custodial care in order to reach a degree of body functioning to permit self care in essential daily living.

A skilled nursing facility (SNF) may be a freestanding facility or part of a hospital that has been certified by Medicare to admit patients requiring subacute care and rehabilitation.

Nursing Home Compare

Nursing Home Compare allows consumers to compare information about nursing homes. It contains quality of care and staffing information for all 15,000 plus Medicare- and Medicaid-participating nursing homes.

Note: Nursing homes aren't included on Nursing Home Compare if they aren't Medicare or Medicaid certified. These Nursing Homes can be licensed by the state.

Information on Nursing Home Compare isn't an endorsement or advertisement for any nursing home and should be considered carefully. Use it with other information you gather about nursing homes facilities. Talk to your doctor or other health care provider about the information on Nursing Home Compare.